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Abstract
Background: Rehabilitation pathways are crucial to reduce stroke-related disability. Motivational Interviewing (MI),
as a person-centered complex intervention, aimed to empower and motivate, and could be a resource to improve
rehabilitation outcomes for older stroke survivors. The IMAGINE project aims to assess the impact of MI, as a
complement to standard geriatric rehabilitation, on functional improvement at 30 days after admission, compared
to standard geriatric rehabilitation alone, in persons admitted to geriatric rehabilitation after a stroke. Secondary
objectives include assessing the impact of MI on physical activity and performance, self-efficacy, safety, cost-utility,
participants’ experiences and functional status at 3 months.
Methods: We will conduct a multicenter randomized clinical trial in three geriatric rehabilitation hospitals in Spain.
Older adults after mild-moderate stroke without previous severe cognitive impairment or disability will be
randomized into the control or intervention group (136 per group, total N = 272). The intervention group will
receive 4 sessions of MI by trained nurses, including the design of a personalized rehabilitation plan agreed
between stroke survivors and nurses based on stroke survivors´ goals, needs, preferences and capabilities. Main
outcome will be the Functional Independence Measure (FIM). In-hospital physical activity will be measured through
accelerometers and secondary outcomes using validated scales. The study includes a process evaluation and cost-
utility analysis.
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Discussion: Final results are expected by end of 2020. This study will provide relevant information on the
implementation of MI as a rehabilitation reinforcement tool in older stroke survivors. A potential reduction in post-
stroke disability and dependence would increase person’s health-related quality of life and well-being and reduce
health and social care costs. IMAGINE has the potential to inform practice and policymakers on how to move
forward towards shared decision-making and shared responsibilities in the vulnerable population of older stroke
survivors.
Trial registration: ClinicalTrials.gov: NCT03434938, registered on January 2018.
Keywords: Stroke, Geriatrics, Rehabilitation, Functional recovery, Physical activity, Motivational interviewing,
Adherence, Clinical trial
Background
Despite the positive advances obtained through acute
treatments, stroke continues to be the leading cause of
long-term disability in adults [1], reaching up to 40% of
residual disability, and representing a huge burden for
health and social systems, as well as for families [2].
Rehabilitation is crucial to reduce the gap between the
persons’ disability and the demands of their environment
[3]. In this sense, there are different interventions that
focus on the different aspects of rehabilitation: some
focus more on physical activity others on cognitive is-
sues and some on regaining activities of daily living.
Post-stroke rehabilitation entails a cyclical process,
which includes: 1) identification of the person’s needs; 2)
set of realistic and reachable goals; 3) implementing in-
terventions according to these goals; and 4) follow-up,
with potential revision of the goals and interventions [3].
Early rehabilitation [4, 5] and shared-goal setting be-
tween stroke survivors and healthcare professionals,
based on the person’s preferences, values, previous rou-
tines and environment [6, 7], increase the odds of
achieving better results [3]. Beneficial aspects include
higher adherence to rehabilitation, increased personal
satisfaction, shorter inpatient stays and greater goal at-
tainment [6, 8]. This is also in line with the International
Classification of Functioning, Disability and Health (ICF)
[9], which promotes patient-professionals communica-
tion, and the terminology of which can be used to struc-
ture assessments, goals and plan interventions [10, 11].
However, patient participation in the process of goal set-
ting is not standard clinical practice and even less so in
geriatric rehabilitation, despite the fact that older per-
sons need, due to their several comorbidities and various
degrees of frailty, more guidance in defining their re-
habilitation goals [12].
Further research has shown that psychological prob-
lems such as depression, apathy, anxiety, emotional and
post-traumatic stress disorder are frequent complica-
tions following a stroke [13], reducing the motivation to
engage in rehabilitation [13, 14]. Several studies have
tested non-pharmacological interventions to reduce
post-stroke psychological problems, such as cognitive-
behavioral techniques and the improvement of social
support networks [15, 16]. Nonetheless, most interven-
tions are designed to be performed one month after the
stroke and not during hospitalization in the acute phase,
thus valuable time to begin and engage in rehabilitation
is delayed [15]. Accordingly, new approaches are
warranted.
Due to the population pyramid change and to the
optimization of primary and secondary prevention treat-
ments, the mean age of people with incident and fatal
stroke has increased and is around 70.4 years old [2],
[17]. Older adults have more frequently physical and
mental comorbidities, and a pre-stroke reduced
functional capacity that can be associated with social
difficulties (i.e., living alone or with an old partner, low
social support) which increase the risk of disability,
institutionalization and death [18, 19]. Despite the high
incidence of stroke in the aging population, older people
with comorbidity and reduced functional ability have
often been excluded from clinical studies precisely be-
cause of their high vulnerability and, therefore, it is ne-
cessary to increase research improving health outcomes
in this segment of the population.
Motivational interviewing (MI) is a person-centered
method where professionals and patients collaborate,
utilizing a goal-oriented style of communication. This
method gives particular attention to the language of
change [20]. MI can be easily adapted to different
healthcare settings and is known to strengthen personal
motivation, empowerment, self-efficacy and commit-
ment to specific personal goals by exploring and identi-
fying the individual’s values and preferences [20]. MI has
also demonstrated efficient in promoting physical activ-
ity, fostering treatment adherence [20, 21], and
improving rehabilitation outcomes [20–22]. MI has been
applied in frail older adults with mobility limitations,
showing that it is safe and has a potential cost-
effectiveness as a rehabilitative person-centered ap-
proach [23]. However, evidence of its effectiveness in
older stroke survivors is lacking.
Gual et al. BMC Geriatrics          (2020) 20:321 Page 2 of 12
The IMAGINE study aims to investigate the effects
of enriching usual geriatric rehabilitation with an
adapted MI approach on different outcomes related
to functional and clinical impact, persons’ satisfac-
tion during hospitalization and cost-utility. We ex-
pect that the IMAGINE study will add a relevant
contribution for the implementation of this interven-
tion in older stroke survivors needing rehabilitation.
Accordingly, this study should inform practice and
policy makers on how to move forward towards
shared decision making and shared responsibilities in
a vulnerable population such as older stroke survi-
vors [24]. With these aims, several hypothesis have
been put forward:
1. MI, conducted during in-patient geriatric rehabilita-
tion with older stroke survivors will result in an im-
provement in functional status at 30 days and 3
months, compared to standard geriatric rehabilita-
tion alone.
2. The MI intervention will induce a statistically and
clinically significant increase in physical activity
during the stay in the geriatric rehabilitation
department, and an improvement in physical
performance, compared to controls.
3. The increase in physical activity and performance
will be dose-correlated with the improvements in
functional status.
4. The intervention will result in a more favorable and
satisfying experience with care during
hospitalization for the participants, caregivers and
professionals involved.
5. Participants will increase their self-efficacy.
6. The intervention will be a cost-effective strategy
to improve participant outcomes at an accept-
able cost (or even with no relevant incremental
costs).
7. The intervention will be safe for the stroke
survivors. An increased number of adverse
events potentially associated to geriatric
rehabilitation and exercise will not be observed




Multicenter randomized clinical trial, with blinded out-
come assessment.
Setting
Geriatric rehabilitation units of three post-acute care
hospitals in Catalonia, Spain.
Population
Older stroke survivors admitted to one of the participat-
ing geriatric rehabilitation units. Inclusion and exclusion
criteria are presented in Table 1.
Randomization and blinding
After inclusion in the study and obtaining informed con-
sent, participants will be randomized centrally to inter-
vention or control group in a concealed allocation
manner. That means that, in each study site, a re-
searcher not involved in the assessments will access the
OxMaR minimization software through a secure web ac-
cess [25], and obtain the participant’s random treatment
allocation. Randomization will be based on the
minimization method, which has proven to provide bal-
anced allocation of study participants in small trials, with
respect to prognostic participant characteristics [26]. For
each participant, treatment allocation will partially de-
pend on the characteristics of the already enrolled par-
ticipants [25]. The prognostic factors included in the
minimization algorithm are: study site, gender (male or
female), and type of stroke (ischemic or hemorrhagic).
Due to the nature of the intervention, participants can-
not be blinded to allocation, but will be strongly advised
not to disclose their allocation status at any assessments.
The assessments will be conducted by a healthcare pro-
fessional (physiotherapist) blinded to treatment alloca-
tion. The assessors are encouraged to maintain the blind
as far as possible, nonetheless, the assessor must report
if the participant allocation was revealed.
Intervention
The aim of the MI intervention, which will be integrated
to the standard geriatric rehabilitation provided in the
participating centers, is to empower, motivate and en-
gage the person in planning and participating in the
rehabilitation plan. The adaptation of the MI inter-
vention is based on a previous pilot study carried out
with older stroke survivors during geriatric rehabilita-
tion, in one of the centers involved in the IMAGINE
study [27]. Figure 1 shows the logic model of the
intervention.
MI will be provided at the hospital ward, either in
the person’s room or in an office nearby, according
to their preferences and mobility. MI will be struc-
tured in four sessions: session 1 will be held one
week from admission; session 2 within 6 days after
the first session; session 3 at 1 week from the second
session; and session 4 will be carried out pre-
discharge.
The common goals for all sessions are:
1) To engage the stoke survivor in his/her care.
Gual et al. BMC Geriatrics          (2020) 20:321 Page 3 of 12
2) Collaborative co-creation of a personalized rehabili-
tation plan, which would complement the routine
geriatric rehabilitation.
3) Reinforce engagement and adherence to the plan to
maintain behavior change and functional
improvement at 3 months.
The emphasis on each of the different goals will vary
according to each MI session (see Fig. 2). Although this
intervention focuses on physical training and function-
ing, during the MI sessions people will be also encour-
aged to perform other recreational, socializing, relaxing
or similar activities during hospitalization, always ac-
cording to individual preferences and objectives.
MI involves the use of different core communication
skills: 1) to ask open questions; 2) to affirm the person’s
particular strengths, abilities, good intentions and efforts;
3) to use reflective listening; 4) to summarize the situ-
ation, and 5) to inform and advise with permission,
which is useful to help people to reach their own con-
clusions about the relevance of any information the
practitioner provides [20]. Each session will follow a
semi-structured format to ensure homogeneity, while
allowing tailoring. Content will generally include: 1)
Creating engagement with the stroke survivor by explor-
ing his/her preferences, values and goals, as well as his/
her knowledge and expectations about stroke rehabilita-
tion and recovery, 2) enhancing motivation by evoking
Fig. 1 Logic model of IMAGINE project
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
1. Older adult (> 60 years old)
2. Admitted to the geriatric rehabilitation unit after a mild-moderate
stroke (ischemic or hemorrhagic, stroke severity at admission assessed
by National Institute of Health Stroke Severity (NIHSS) scale < 17 points)
3. Able to provide informed consent, personally or by caregiver.
1. Previous diagnosis of dementia (ascertained from medical records)
2. Severe post-stroke cognitive impairment (Pfeiffer SMPQ> 7 errors)
3. Persistent delirium (> 7 days) after admission in the rehabilitation unit
4. Previous severe disability in activities of daily living (pre-stroke Barthel
index < 20/100 points)
5. Severe stroke which might limit recovery (NIHSS> 16)
6. Aphasia or other problems hampering communication
7. Advanced and/or terminal condition (life expectancy not exceeding
6months).
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strengths and abilities of the person, 3) follow-up and
reinforcement, and 4) adapting the plan to the improved
abilities and to home setting. As a practical milestone,
during the second session the stroke survivor will estab-
lish tailored goals to complement standard rehabilita-
tion, aimed at increasing involvement in self-care and
daily living activities. When appropriate, in some cases
debriefing with other professionals involved in the re-
habilitation (physical therapists, occupational therapist
or nursing staff) will be scheduled, to tailor and adjust
the rehabilitation plan considering the functional situ-
ation. Figure 2 displays the structure of each session and
specific criteria to conduct the additional interview be-
tween sessions three and four in case of external or in-
ternal modulators (which might have undermined the
interviews). MI will be delivered by nurses trained
through a certified MI course, and additional coaching
by a psychiatrist who is a certified MI trainer will be of-
fered to them throughout the intervention period (two
group meetings per year and on demand individual
sessions). During the study, quality control of the MI
sessions using Motivational Interviewing Treatment In-
tegrity (MITI) Code 3.1.1 [28] will be performed through
video recording of a random selection of sessions.
Control group
The control group will receive standard geriatric re-
habilitation. Routine geriatric rehabilitation in post-acute
centers in Catalonia is homogeneous in terms of process
and outcome indicators and general staff/patients ratios
are marked by the Department of Health [29]. Standard
geriatric rehabilitation includes a multidisciplinary and
individualized rehabilitation plan, which incorporates
physiotherapy, occupational therapy and speech therapy.
This plan is established after a comprehensive multidis-
ciplinary geriatric assessment, and shared through the
electronic health records.
Outcome assessments
All outcome assessments will be performed by trained
physiotherapists, certified to use the Functional
Independence Measure (FIM) and blinded to treatment
allocation. Table 2 summarizes assessment tools admin-
istered in this study and the specific assessment time pe-
riods of each one. We will monitor and record whether
group allocation is revealed during the outcome
assessment.
Primary outcome measures
Functional Independence Measure (FIM), validated for
use in stroke survivors [30], is a sensitive and compre-
hensive tool to assess the level of independence in basic
activities of daily living, which is considered the golden
standard for stroke rehabilitation. The scale includes 18
items, grouped into 2 subscales: 1) motor and 2) cogni-
tion. Each item is scored on a 7-point ordinal scale (1–7,
higher values indicating more independence). Combined
motor (13–91 points) and cognitive (5–35 points)
Fig. 2 Structure and main contents of MI sessions
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Table 2 Schedule of enrolment, interventions, and assessments for the IMAGINE study
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subscale scores provide the total score (18–126 points;
higher values indicating more independence). In this
study, a version translated into Spanish was
administered.
Secondary outcome measures
 Complementary measures of function/disability. The
Modified-Rankin Scale (m-RS) is a short measure of
disability and dependence, routinely used for 3
months clinical follow-up, and rated in an ordinal
scale with 6 categories ranging from zero (no symp-
toms) to five (complete physical dependence). A sev-
enth category can be added to signify death [31]. In
this study, a version translated into Spanish was
administered.
 In-hospital physical activity will be measured once
through accelerometers, placing ActivPAL® devices
on the preserved leg during 7 consecutive in-
hospital days, to measure mainly time spent sitting
and standing. This device has been validated in post-
acute stroke samples [32, 33].
 Physical performance improvement will be
measured using the Spanish validated version of the
Short Physical Performance Battery (SPPB) (0–12
points, worse–best), which includes sub-tests of bal-
ance, strength and gait speed [34].
 Adverse events registration will include: falls,
fractures, cranial traumatism, pain (Visual Analogue
Scale from 0 to 10 points), cardiovascular events
(angina, myocardial infarction, TIA, stroke),
aspiration pneumonia/respiratory infections,
readmissions to acute hospitals and death.
 General Self-Efficacy scale [35] is a 10-item tool de-
signed to assess optimistic self-beliefs to cope with a
variety of difficult demands in life. This scale is dir-
ectly correlated to emotion, optimism and work sat-
isfaction. The total score ranges between 10 and 40,
with a higher score indicating more self-efficacy.
Negative correlations are found with depression,
stress, health complaints, burnout, and anxiety.
 Montreal Cognitive Assessment (MOCA) [36] is a
brief instrument recommended for cognitive
impairment (CI) screening in people who have
suffered a stroke or TIA. It is sensitive to changes in
acute temporary CI after mild stroke/TIA [37]. The
test assesses visuospatial abilities, short-term mem-
ory, executive functions, language and fluency, ab-
straction thinking, orientation, attention,
concentration, and working memory. The scale in-
cludes 10 questions (total score range 0–30). Higher
scores indicate higher cognitive performance.
 Mental health: Depressive symptoms by means of
the Yesavage Geriatric Depression Scale (GDS)
15 items (0–15 points; worse – best) [38] and
the mental wellbeing with the Warwick-
Edinburgh Mental Well-being Scale (WEMWBS),
which includes 14 questions with answers coded
from 1 ‘Never’ to 5 ‘Always’ (14–70 points, worst
– best) [39].
 Duke Social Support Index 11 items (DUKE-UNK-
11) will be used to assess social support and effective
social contacts during the rehabilitation process,
effective caregiver at home, and perceived social
support (11–55 points; lower – higher social
support) [40].
 Care results. We will collect data on length of stay
(days), discharge destination (home, nursing home,
long-term care, acute hospital, death), and hours of
rehabilitation.
 Participation in leisure activities during admission
and after-discharge, reported by nurses, stroke survi-
vors and / or caregivers, will be collected.
 Rehabilitation efficiency. Scores will be computed in
terms of improvement of FIM/length of stay.
 Quality of life. A generic measure of quality of life
will be obtained using the EQ-5D-5L tool, which in-
cludes two components. A health state description
comprises 5 items assessing the dimensions of mo-
bility, self-care, usual activities, pain/discomfort, and
anxiety/depression and evaluation, via categorical
questions. An evaluation part using a Visual Ana-
logues Scale for retrieving from respondents an
overall judgment on their health in a scale from 0 to
100 [41, 42].
Covariates assessed at admission
 Socio-demographic variables: age, gender, civil and
marital status.
 Clinical data: Stroke characteristics (ischemic/
hemorrhagic, Oxfordshire CSPC, acute treatment,
etiology) clinical variables such as chronic diseases
and comorbidity measured by a Spanish translated
version of the Charlson index [43] will be collected.
In addition, type and number of pharmacological
treatment, nutritional status with the Spanish
validated version of the Mini Nutritional
Assessment-Short form (MNA-sf) [44].
Procedure
Table 2 depicts full procedures of the project.
In case of discharge before 30 days, the follow-up as-
sessment will be performed the day of discharge, always
registering the date of the assessment. In case of un-
planned discharge (e.g. to emergency/acute hospital), we
will collect at least routine available data collected in the
rehabilitation unit and administrative data. The 3
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months assessment will be performed either at an outpa-
tient’s clinic or at the participant’s home. If face-to-face
follow-up is not possible, a telephone assessment can be
conducted. In all cases, assessment will include at least
the telephone version of: Barthel, Rankin, Lawton, FIM,
FAC, GSE, DUKE-UNK-11, GDS-15, EQ-5D.
Process evaluation
Since MI intervention is a complex intervention, as ob-
served in Fig. 1 (logic model), the trial includes a process
evaluation to enhance the interpretation of the results of
effectiveness. This is based on the Medical Research
Council (MRC) guidance [45, 46], and focuses on how
the context, implementation and impact mechanisms
might influence each other and shape outcomes. Specif-
ically, we will assess: 1) the quantity and quality of what
is delivered (implementation); 2) the generalizability of
the effectiveness by understanding the role of context
and the comparability between intervention sites; 3) the
mechanisms of impact; and 4) perceived impacts and ad-
verse events.
Each assessment will be addressed complementarily by
quantitative and qualitative methodological procedures.
Observation checklists and attendance registry will be
conducted after each MI session by the interviewer.
These procedures will collect information on fidelity
(achievement of goals and tasks of each session), dose
and adverse events. Standardized scales (i.e. self-
efficacy) will be included in the baseline, post-
intervention and follow-up assessments to explore
mechanisms of impact according to the logic model.
Contextual characteristics will be collected in a semi-
structured questionnaire to capture shared and spe-
cific features of each intervention site.
Complementarily, a qualitative evaluation will be
used to explore participant experiences with the im-
plementation of the intervention, their personal and
social context, the mechanisms of impact and their
perceived effects as well as unexpected events. It will
consist in in-depth interviews at 30 days and at 3
months on a purposeful sample of participants, se-
lected to maximize variability by gender, disability
levels, socio-economic levels, and social support. In
addition, a purposeful sample of caregivers and pro-
fessionals who performed the intervention will be also
interviewed. Finally, a focus group with reference re-
habilitation professionals of the units will be con-
ducted in each intervention site.
The process evaluation will be done by a MD and a
social worker with great experience in qualitative ana-
lysis, designing complex evaluations and process evalu-
ation. These professionals will not have another role in
this project. The results will be reported at completion.
Sample size calculation & statistical analysis
Sample size calculation is based on the results of previ-
ous RCTs assessing the effect of geriatric rehabilitation
on improvement of the FIM. Accordingly, it is expected
that geriatric rehabilitation will induce a 20 points im-
provement in FIM between admission and discharge
[47]. This change has been established as “minimal clin-
ically meaningful” improvement [48]. It is expected that
MI plus geriatric rehabilitation will result in a “moder-
ately relevant” clinical improvement in FIM, estimated
to be 30 points. That is, MI will induce an additional
improvement of 10 points (which corresponds to ap-
proximately 10% of total FIM score), compared to the
control group. Considering a common standard devi-
ation of 27.9 points in FIM, a 10% of drop-out rate
at 30 days, and accepting an alfa risk of 0.05 and a
beta risk of 0.2 in a bilateral contrast, we would need
to include 136 stroke survivors in each branch (total
sample = 272) to detect this improvement as statisti-
cally significant. Calculations were obtained using the
GRANMO program [49].
Descriptive statistics will be presented for the overall
characteristics of the study sample (intervention and
control group) as frequencies and percentages for nom-
inal or categorical variables and means and standard de-
viations for continuous ones. Baseline comparisons
between treatment groups will be assessed as t-tests and
chi-square tests, to check for potential imbalances in
group composition and characteristics.
The effect of MI in the change in total FIM score be-
tween baseline and follow up (30 days) will be explored
through a longitudinal repeated-measures mixed effects
linear model, with the total FIM score as dependent
variable, and a 2-level fixed factor accounting for the
treatment group (MI or control). The model will adjust
for clinically relevant covariates, such as age, gender and
the amount of physical activity.
Group analyses will be carried out on an intention-to-
treat principle. Missing data will be replaced by multiple
imputations, after conducting explorations of the pos-
sible missingness mechanisms.
Cost-utility analysis will be also performed to compare
the benefit and costs of a MI programs. Cost-utility will
be measured as the ratio between direct costs (workforce
time use to deliver the MI intervention and the related
training and supervision, supplementary tests, use of
other hospital resources, medical visits, readmissions,
treatments, ambulatory rehabilitation, etc.) during
hospitalization and also post-discharge (at 3 months)
and Quality Adjusted Life Years (QALYs). QALYs will
be derived using the EQoL-5D before and after the treat-
ment and at 3 months. Therefore, cost-utility will be
calculated as the incremental ratio in € for 1 QALYs in
the intervention vs. control group [50, 51].
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All analyses will be carried out in Stata 15 (StataCorp.
2017. Stata Statistical Software: Release 15. College Sta-
tion, TX: StataCorp LLC).
Legal and ethical aspects
The protocol and the template informed consent forms
has been approved by the Ethics Committee on Animal
and Human Research (CEEAH) of the Universitat
Autònoma de Barcelona (reference number CEEAH
3715). The rest of the participating centers’ Ethics Com-
mittees ratified these premises. At the beginning of the
project, an advisory board will be created including
stroke survivors’ and caregivers’ representatives (from
dedicated Associations or from the participating institu-
tions), health and social care professionals and
policymakers, which will meet periodically with the re-
search team. The commission of this board will be to: 1)
support and give feedback about the refinement of the
study and intervention design; 2) promote constant feed-
back on project progress and help to overcome potential
barriers; 3) foster communication, dissemination and
knowledge translation.
Prior to any assessment and intervention, all partici-
pants in the study granted written and verbal informed
consent.
All study-related information will be stored securely at
the reference center Server. All participant information
will be stored in locked file cabinets in areas with limited
access. All reports, data collection, process, and adminis-
trative forms will be identified by a coded ID number
only to maintain participant confidentiality. All records
that contain names or other personal identifiers, such as
informed consent forms, will be stored separately from
study records identified by code number. All local data-
bases will be secured with password-protected access
systems. Forms, lists, logbooks, appointment books, and
any other listings that link participant ID numbers to
other identifying information will be stored in a separate,
locked file in an area with limited access.
The coordinator of each intervention site will be given
access to the cleaned data sets, housed on the file trans-
fer protocol site created for the study, and all data sets
will be password protected. Project Principal Investiga-
tors will have direct access to their own site’s data sets,
and will have access to other sites data by request. To
ensure confidentiality, data shared with project team
members will be completely anonymized without any
identifying participant information.
The feasibility and scientific quality of the trial has
been peer-reviewed and approved by the Principal Inves-
tigators and Research and Development team. The trial
protocol will permit its reporting in line with the
Consolidated Standards of Reporting Trials (CONSORT)
guidelines [26]. The Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
checklist [52, 53], and the Template for intervention de-
scription and replication (TIDieR) checklist [54] are both
provided as additional files 1 and 2.
Results
Final results are expected by end of 2020. See flow chart
(Fig. 3).
Discussion
This project is expected to provide new evidence on the
impact of MI on older stroke survivors, increasing the
understanding on the implementation of a non-
pharmacological intervention based on a person-
centered approach, and assessing its impacts on
objective outcomes. The project will be performed from
a “triple aim” viewpoint (healthcare, efficiency and
person-centered outcomes and experiences), through
multi quantitative and qualitative methods. Accordingly,
the IMAGINE study will develop a new area of research
with an innovative approach: empowering older stroke
survivors that are in vulnerable conditions, and building
their rehabilitation process with them rather than only
for them. Thus, it changes the person’s perspective from
his/her limitations to his/her strengths. In the same line,
this study focuses on a novel approach by fostering re-
sidual capacities based on personal goals instead of
“treating disability”, in line with novel frameworks [10,
55]. The MI approach can easily be part of professional
training or configure novel specialty training for health-
care professionals involved in rehabilitation services,
providing a unique opportunity of scaling up the inter-
vention. The focus on person centered care is expected
to increase person satisfaction, which will be assessed by
exploring the experiences of the stroke survivors and
professionals involved. In addition, the trial is based on
objective outcomes that are relevant for older stroke sur-
vivors, since mobility and physical function limitations
are a major barrier for quality of life. We will also assess
other aspects such as well-being or self-efficacy, as a
health resource with major influence on quality of life
and with potential to explain the mechanisms of impact
of the MI intervention.
Regarding stroke survivors, MI has been used mainly
in chronic stages in order to promote and maintain
pharmacological treatment and lifestyle changes [32, 56,
57]. Recently, two research groups have described a pos-
sible association between the early use of MI, functional
and mood improvement and a reduction of mortality
[58, 59]. However, as none of these studies focused on
older adults, the evidence of its use during the subacute
phase of stroke in older adults is scarce [60]. Similarly,
English et al. [32] assessed the feasibility of MI in a small
sample (N = 35) of stroke survivors (> 6months) in the
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community. They also assessed the impact on physical
activity, as the reduction of sitting time measured using
accelerometers. The intervention was found feasible and
safe but the observed sitting time reduction was not
significantly different from the control group. Recent stud-
ies on frail older adults with mobility limitations from the
community have confirmed safety and showed potential
cost-effectiveness of a rehabilitative person-centered ap-
proach [23]. These results are in line with other studies
that suggest cost-effectiveness [23, 61], and cost-utility
[62, 63] of MI used to promote changes in lifestyle, in dif-
ferent settings and populations. However, such studies
have not been carried out with stroke survivors.
Potential critical aspects and risks might be an insuffi-
cient sample size or important attrition; although in case
of need, other geriatric rehabilitation centers of the
Catalan healthcare network (Catsalut) could be included.
Strengths of the study are the three intervention sites,
referent centers for geriatric stroke rehabilitation in
Catalonia, who have also previously shown their
recruitment capability. Moreover, our previous MI pilot
[27] showed high acceptance of the intervention, which
should reduce the risk of dropouts. Although in a non-
pharmacologic trial it is almost impossible to blind par-
ticipants and professionals delivering the intervention,
procedures have been set to guarantee as much as pos-
sible blinding outcome assessors.
This project has the potential to directly change the de-
cision making process in the rehabilitation of older stroke
survivors. As almost half of stroke survivor’s experience
relevant residual disability, with stroke being the main
cause of disability in Western countries [2], new rehabili-
tation and recovery strategies are needed and will have a
high impact for the society. Likewise, the knowledge
gained by this project, including the intervention and its
effects also in terms of costs, should inform current health
care policies at national and international level on how to
enhance established rehabilitation programs with an
empowering approach, thus taking a major profit of cur-
rently limited economic and human resources.
Fig. 3 Flow chart
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